CONFLICTS OF INTEREST
Dr. Christopher Warren has served as an epidemiological consultant for
Alladapt Immunotherapeutics and Before Brands
Dr. Hemant Sharma receives research grant support from Aimmune
Therapeutics, DBV Technologies, Regeneron, Food Allergy Research &
Education (FARE), and the National Institutes of Health (NIH).
Dr. Tobin receives research grant support from The National Institutes
of Health (NIH) and Stanford Sean N. Parker Center for Allergy Research.
Dr. Assa’ad receives grant support from Aimmune Therapeutics, DBV
Technologies, Sanofi Aventis, Astellas, AstraZeneca, Regeneron and NIH.
Dr. Gupta receives research grant support from The National Institutes
of Health (NIH), Food Research & Education (FARE), Stanford Sean N.
Parker Center for Allergy Research, UnitedHealth Group, Thermo Fisher
Scientific, Genentech, and the National Confectioners Association (NCA);
and has served as a medical consultant/advisor for Aimmune Therapeutics,
Genentech, Before Brands, Kaléo, DBV Technologies, ICER, DOTS
Technology, and Food Allergy Research and Education (FARE).
The other authors do not have any conflicts of interest to disclose.